Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Nov;75(11):1575–1583. doi: 10.1136/jnnp.2003.029132

The longer term outcome of children born to mothers with epilepsy

N Adab 1, U Kini 1, J Vinten 1, J Ayres 1, G Baker 1, J Clayton-Smith 1, H Coyle 1, A Fryer 1, J Gorry 1, J Gregg 1, G Mawer 1, P Nicolaides 1, L Pickering 1, L Tunnicliffe 1, D Chadwick 1
PMCID: PMC1738809  PMID: 15491979

Abstract

Objectives: To determine the prevalence of cognitive delay and possible associated dysmorphic features in children exposed to antiepileptic drugs (AEDs) in utero.

Design: Retrospective study of children born to mothers with epilepsy.

Setting: Regional epilepsy clinics in Liverpool and Manchester, UK.

Participants: Children aged between 6 months and 16 years born to mothers with epilepsy.

Main outcome measures: Structured interviews, hospital records, clinical examination, and psychometric tests (Wechsler) were used to assess exposure and intelligence quotient (IQ). Blinded assessment of photographs was used to score children with characteristic dysmorphic features.

Results: A total of 249 children aged 6 and over were studied: 41 were exposed to sodium valproate, 52 to carbamazepine, 21 to phenytoin, 49 to polytherapy, and 80 were unexposed. Mean verbal IQ was significantly lower in the valproate group compared to unexposed and other monotherapy groups. Multiple regression analysis showed that both valproate exposure and frequent tonic-clonic seizures in pregnancy were significantly associated with a lower verbal IQ despite adjusting for other confounding factors. There was a significant negative correlation between dysmorphic features and verbal IQ in children exposed to valproate.

Conclusions: This study identifies valproate as a drug carrying potential risks for developmental delay and cognitive impairment and is the first to suggest that frequent tonic-clonic seizures have a similar effect. Our results need to be interpreted with caution given their retrospective nature. Women with epilepsy need careful counselling about individual risk benefit of AED treatment before pregnancy.

Full Text

The Full Text of this article is available as a PDF (144.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adab N., Jacoby A., Smith D., Chadwick D. Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry. 2001 Jan;70(1):15–21. doi: 10.1136/jnnp.70.1.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Battino D., Binelli S., Caccamo M. L., Canevini M. P., Canger R., Como M. L., Croci D., De Giambattista M., Granata T., Pardi G. Malformations in offspring of 305 epileptic women: a prospective study. Acta Neurol Scand. 1992 Mar;85(3):204–207. doi: 10.1111/j.1600-0404.1992.tb04029.x. [DOI] [PubMed] [Google Scholar]
  3. Clayton-Smith J., Donnai D. Fetal valproate syndrome. J Med Genet. 1995 Sep;32(9):724–727. doi: 10.1136/jmg.32.9.724. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dean J. C. S., Hailey H., Moore S. J., Lloyd D. J., Turnpenny P. D., Little J. Long term health and neurodevelopment in children exposed to antiepileptic drugs before birth. J Med Genet. 2002 Apr;39(4):251–259. doi: 10.1136/jmg.39.4.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dean J. C., Moore S. J., Osborne A., Howe J., Turnpenny P. D. Fetal anticonvulsant syndrome and mutation in the maternal MTHFR gene. Clin Genet. 1999 Sep;56(3):216–220. doi: 10.1034/j.1399-0004.1999.560306.x. [DOI] [PubMed] [Google Scholar]
  6. Delgado-Escueta A. V., Enrile-Bacsal F. Juvenile myoclonic epilepsy of Janz. Neurology. 1984 Mar;34(3):285–294. doi: 10.1212/wnl.34.3.285. [DOI] [PubMed] [Google Scholar]
  7. DiLiberti J. H., Farndon P. A., Dennis N. R., Curry C. J. The fetal valproate syndrome. Am J Med Genet. 1984 Nov;19(3):473–481. doi: 10.1002/ajmg.1320190308. [DOI] [PubMed] [Google Scholar]
  8. Fairgrieve S. D., Jackson M., Jonas P., Walshaw D., White K., Montgomery T. L., Burn J., Lynch S. A. Population based, prospective study of the care of women with epilepsy in pregnancy. BMJ. 2000 Sep 16;321(7262):674–675. doi: 10.1136/bmj.321.7262.674. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gaily E., Granström M. L. Minor anomalies in children of mothers with epilepsy. Neurology. 1992 Apr;42(4 Suppl 5):128–131. [PubMed] [Google Scholar]
  10. Gaily E., Kantola-Sorsa E., Granström M. L. Intelligence of children of epileptic mothers. J Pediatr. 1988 Oct;113(4):677–684. doi: 10.1016/s0022-3476(88)80377-9. [DOI] [PubMed] [Google Scholar]
  11. Gaily E., Kantola-Sorsa E., Granström M. L. Specific cognitive dysfunction in children with epileptic mothers. Dev Med Child Neurol. 1990 May;32(5):403–414. doi: 10.1111/j.1469-8749.1990.tb16959.x. [DOI] [PubMed] [Google Scholar]
  12. Gaily E., Kantola-Sorsa E., Hiilesmaa V., Isoaho M., Matila R., Kotila M., Nylund T., Bardy A., Kaaja E., Granström M-L. Normal intelligence in children with prenatal exposure to carbamazepine. Neurology. 2004 Jan 13;62(1):28–32. doi: 10.1212/wnl.62.1.28. [DOI] [PubMed] [Google Scholar]
  13. Hanson J. W., Myrianthopoulos N. C., Harvey M. A., Smith D. W. Risks to the offspring of women treated with hydantoin anticonvulsants, with emphasis on the fetal hydantoin syndrome. J Pediatr. 1976 Oct;89(4):662–668. doi: 10.1016/s0022-3476(76)80414-3. [DOI] [PubMed] [Google Scholar]
  14. Harper P. S., Lim C., Craufurd D. Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium. J Med Genet. 2000 Aug;37(8):567–571. doi: 10.1136/jmg.37.8.567. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hill R. M., Verniaud W. M., Horning M. G., McCulley L. B., Morgan N. F. Infants exposed in utero to antiepileptic drugs. A prospective study. Am J Dis Child. 1974 May;127(5):645–653. doi: 10.1001/archpedi.1974.02110240031002. [DOI] [PubMed] [Google Scholar]
  16. Holmes L. B., Harvey E. A., Coull B. A., Huntington K. B., Khoshbin S., Hayes A. M., Ryan L. M. The teratogenicity of anticonvulsant drugs. N Engl J Med. 2001 Apr 12;344(15):1132–1138. doi: 10.1056/NEJM200104123441504. [DOI] [PubMed] [Google Scholar]
  17. Ikeda Akio, Miyamoto Susumu, Shibasaki Hiroshi. Cortical motor mapping in epilepsy patients: information from subdural electrodes in presurgical evaluation. Epilepsia. 2002;43 (Suppl 9):56–60. doi: 10.1046/j.1528-1157.43.s.9.13.x. [DOI] [PubMed] [Google Scholar]
  18. Jones K. L., Lacro R. V., Johnson K. A., Adams J. Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med. 1989 Jun 22;320(25):1661–1666. doi: 10.1056/NEJM198906223202505. [DOI] [PubMed] [Google Scholar]
  19. Kaneko S., Battino D., Andermann E., Wada K., Kan R., Takeda A., Nakane Y., Ogawa Y., Avanzini G., Fumarola C. Congenital malformations due to antiepileptic drugs. Epilepsy Res. 1999 Feb;33(2-3):145–158. doi: 10.1016/s0920-1211(98)00084-9. [DOI] [PubMed] [Google Scholar]
  20. Leavitt A. M., Yerby M. S., Robinson N., Sells C. J., Erickson D. M. Epilepsy in pregnancy: developmental outcome of offspring at 12 months. Neurology. 1992 Apr;42(4 Suppl 5):141–143. [PubMed] [Google Scholar]
  21. Lhatoo S. D., Johnson A. L., Goodridge D. M., MacDonald B. K., Sander J. W., Shorvon S. D. Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol. 2001 Mar;49(3):336–344. [PubMed] [Google Scholar]
  22. Majewski F., Steger M., Richter B., Gill J., Rabe F. The teratogenicity of hydantoins and barbiturates in humans, with considerations on the etiology of malformations and cerebral disturbances in the children of epileptic parents. Int J Biol Res Pregnancy. 1981;2(1):37–45. [PubMed] [Google Scholar]
  23. Marson Anthony G., Williamson Paula R., Clough Helen, Hutton Jane L., Chadwick David W., Epilepsy Monotherapy Trial Group Carbamazepine versus valproate monotherapy for epilepsy: a meta-analysis. Epilepsia. 2002 May;43(5):505–513. doi: 10.1046/j.1528-1157.2002.20801.x. [DOI] [PubMed] [Google Scholar]
  24. Mawer George, Clayton-Smith Jill, Coyle Helen, Kini Usha. Outcome of pregnancy in women attending an outpatient epilepsy clinic: adverse features associated with higher doses of sodium valproate. Seizure. 2002 Dec;11(8):512–518. doi: 10.1016/s1059-1311(02)00135-8. [DOI] [PubMed] [Google Scholar]
  25. Moore S. J., Turnpenny P., Quinn A., Glover S., Lloyd D. J., Montgomery T., Dean J. C. A clinical study of 57 children with fetal anticonvulsant syndromes. J Med Genet. 2000 Jul;37(7):489–497. doi: 10.1136/jmg.37.7.489. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Nicolson A., Appleton R. E., Chadwick D. W., Smith D. F. The relationship between treatment with valproate, lamotrigine, and topiramate and the prognosis of the idiopathic generalised epilepsies. J Neurol Neurosurg Psychiatry. 2004 Jan;75(1):75–79. [PMC free article] [PubMed] [Google Scholar]
  27. Nulman I., Scolnik D., Chitayat D., Farkas L. D., Koren G. Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. Am J Med Genet. 1997 Jan 10;68(1):18–24. [PubMed] [Google Scholar]
  28. Ornoy A., Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child. 1996 Dec;75(6):517–520. doi: 10.1136/adc.75.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ornoy A., Cohen E. Outcome of children born to epileptic mothers treated with carbamazepine during pregnancy. Arch Dis Child. 1996 Dec;75(6):517–520. doi: 10.1136/adc.75.6.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pearce J. M. Howard Henry Tooth (1856-1925). J Neurol. 2000 Jan;247(1):3–4. doi: 10.1007/s004150050002. [DOI] [PubMed] [Google Scholar]
  31. Samrén E. B., van Duijn C. M., Koch S., Hiilesmaa V. K., Klepel H., Bardy A. H., Mannagetta G. B., Deichl A. W., Gaily E., Granström M. L. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy. Epilepsia. 1997 Sep;38(9):981–990. doi: 10.1111/j.1528-1157.1997.tb01480.x. [DOI] [PubMed] [Google Scholar]
  32. Scolnik D., Nulman I., Rovet J., Gladstone D., Czuchta D., Gardner H. A., Gladstone R., Ashby P., Weksberg R., Einarson T. Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. JAMA. 1994 Mar 9;271(10):767–770. [PubMed] [Google Scholar]
  33. Shapiro S., Hartz S. C., Siskind V., Mitchell A. A., Slone D., Rosenberg L., Monson R. R., Heinonen O. P. Anticonvulsants and parental epilepsy in the development of birth defects. Lancet. 1976 Feb 7;1(7954):272–275. doi: 10.1016/s0140-6736(76)91403-3. [DOI] [PubMed] [Google Scholar]
  34. Shorvon S. Antiepileptic drug therapy during pregnancy: the neurologist's perspective. J Med Genet. 2002 Apr;39(4):248–250. doi: 10.1136/jmg.39.4.248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Speidel B. D., Meadow S. R. Maternal epilepsy and abnormalities of the fetus and newborn. Lancet. 1972 Oct 21;2(7782):839–843. doi: 10.1016/s0140-6736(72)92209-x. [DOI] [PubMed] [Google Scholar]
  36. Steinhausen H. C., Lösche G., Koch S., Helge H. The psychological development of children of epileptic parents. I. Study design and comparative findings. Acta Paediatr. 1994 Sep;83(9):955–960. doi: 10.1111/j.1651-2227.1994.tb13180.x. [DOI] [PubMed] [Google Scholar]
  37. Tennis Patricia, Eldridge R. R., International Lamotrigine Pregnancy Registry Scientific Advisory Committee Preliminary results on pregnancy outcomes in women using lamotrigine. Epilepsia. 2002 Oct;43(10):1161–1167. doi: 10.1046/j.1528-1157.2002.45901.x. [DOI] [PubMed] [Google Scholar]
  38. Vanoverloop D., Schnell R. R., Harvey E. A., Holmes L. B. The effects of prenatal exposure to phenytoin and other anticonvulsants on intellectual function at 4 to 8 years of age. Neurotoxicol Teratol. 1992 Sep-Oct;14(5):329–335. doi: 10.1016/0892-0362(92)90039-d. [DOI] [PubMed] [Google Scholar]
  39. Wallace H., Shorvon S., Tallis R. Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy. Lancet. 1998 Dec 19;352(9145):1970–1973. doi: 10.1016/S0140-6736(98)04512-7. [DOI] [PubMed] [Google Scholar]
  40. Wide K., Henning E., Tomson T., Winbladh B. Psychomotor development in preschool children exposed to antiepileptic drugs in utero. Acta Paediatr. 2002;91(4):409–414. doi: 10.1080/080352502317371643. [DOI] [PubMed] [Google Scholar]
  41. van der Pol M. C., Hadders-Algra M., Huisjes H. J., Touwen B. C. Antiepileptic medication in pregnancy: late effects on the children's central nervous system development. Am J Obstet Gynecol. 1991 Jan;164(1 Pt 1):121–128. doi: 10.1016/0002-9378(91)90640-d. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES